In our recent study, we reported that the F-box protein FBXO44 plays an essential role in H3K9me3-mediated transcriptional silencing of REs in cancer cells and this process could provide a therapeutic opportunity for cancer treatment. This evidence concerns the gene FBXO44 and cancer.